Bosentan is a dual endothelin receptor antagonist used in the treatment of pulmonary arterial hypertension by blocking endothelin-1 from binding to its receptors, thereby inhibiting vasoconstriction and… Read more






![Chemical structure of Ethyl 2-(4-(N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)sulfamoyl)phenyl)-2-methylpropanoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FEthyl-2-4-N-6-2-hydroxyethoxy-5-2-methoxyphenoxy-22-bipyrimidin-4-ylsulfamoylphenyl-2-methylpropanoate.png&w=3840&q=75)
![Chemical structure of Ethyl 2-(4-(N-(6-chloro-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)sulfamoyl)phenyl)-2-methylpropanoate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FEthyl-2-4-N-6-chloro-5-2-methoxyphenoxy-22-bipyrimidin-4-ylsulfamoylphenyl-2-methylpropanoate.png&w=3840&q=75)






![Chemical structure of N,N'-[5-(2-Methoxyphenoxy)[2,2'-bipyrimidine]-4,6-diyl]bis[4-(1,1-dimethylethyl)benzenesulfonamide]](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1218951-81-5-NN-5-2-Methoxyphenoxy22-bipyrimidine-46-diylbis4-11-dimethylethylbenzenesulfonamide.png&w=3840&q=75)
![Chemical structure of N-(6-(2-(Sec-butoxy)ethoxy)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)-4-(tert-butyl)benzenesulfonamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-6-2-Sec-butoxyethoxy-5-2-methoxyphenoxy-22-bipyrimidin-4-yl-4-tert-butylbenzenesulfonamide.png&w=3840&q=75)
![Chemical structure of N-(6-(2-(tert-Butoxy)ethoxy)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)-4-(tert-butyl)benzenesulfonamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F301646-60-6-N-6-2-tert-Butoxyethoxy-5-2-methoxyphenoxy-22-bipyrimidin-4-yl-4-tert-butylbenzenesulfonamide.png&w=3840&q=75)
![Chemical structure of N-(6-(2-Hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)-4-(2-methyl-1-((tetrahydro-2H-pyran-2-yl)oxy)propan-2-yl)benzenesulfonamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-6-2-Hydroxyethoxy-5-2-methoxyphenoxy-22-bipyrimidin-4-yl-4-2-methyl-1-tetrahydro-2H-pyran-2-yloxypropan-2-ylbenzenesulfonamide.png&w=3840&q=75)
![Chemical structure of N-(6-Chloro-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)-4-(2-methyl-1-((tetrahydro-2H-pyran-2-yl)oxy)propan-2-yl)benzenesulfonamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-6-Chloro-5-2-methoxyphenoxy-22-bipyrimidin-4-yl-4-2-methyl-1-tetrahydro-2H-pyran-2-yloxypropan-2-ylbenzenesulfonamide.png&w=3840&q=75)
![Chemical structure of N-(6-Chloro-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)-4-isopropylbenzenesulfonamide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1268612-25-4-N-6-Chloro-5-2-methoxyphenoxy-22-bipyrimidin-4-yl-4-isopropylbenzenesulfonamide.png&w=3840&q=75)
![Chemical structure of Potassium ((4-(tert-butyl)phenyl)sulfonyl)(6-chloro-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)amide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F301646-59-3-Potassium-4-tert-butylphenylsulfonyl6-chloro-5-2-methoxyphenoxy-22-bipyrimidin-4-ylamide.png&w=3840&q=75)
Bosentan is a dual endothelin receptor antagonist used in the treatment of pulmonary arterial hypertension by blocking endothelin-1 from binding to its receptors, thereby inhibiting vasoconstriction and vascular proliferation. This category provides a comprehensive selection of Bosentan reference standards, including the active pharmaceutical ingredient, its metabolites, and various process-related or degradation impurities. These high-quality materials are essential for pharmaceutical laboratories to perform accurate impurity profiling, method validation, and routine quality control testing required for batch release and regulatory compliance. Additionally, the collection includes stable isotope labelled compounds, which serve as critical internal standards in mass spectrometry to enhance the sensitivity and precision of pharmacokinetic and bioanalytical assays. By utilizing these structurally verified standards, researchers can effectively characterize drug substance purity and ensure consistent quality throughout the development and manufacturing lifecycle of pharmaceutical products.